Salivary markers of hepato-metabolic comorbidities in pediatric obesity
Digestive and Liver Diseases Nov 22, 2018
Jacopo T, et al. - In this analysis, the diagnostic role of combined salivary uric acid (UA), glucose and insulin levels to screen noninvasively for metabolic syndrome (MetS) and nonalcoholic fatty liver disease was investigated. Consideration was given to medical, clinical, anthropometric and laboratory data including serum triglyceride, glucose, insulin, HOMA, HDL-cholesterol and UA levels of 23 obese children (15 with [St + ] and 8 without [St–] ultrasonographic hepatic steatosis) and 18 normal weight controls. Findings suggested that salivary testing along with selected anthropometric parameters helps to identify noninvasively obese children with hepatic steatosis and/or MetS components.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries